But how do you choose between Mounjaro vs
The phase 2 Exenatide PD2 trial reported a 3.5-point improvement on the Movement Disorder Society Unified Parkinsons Disease Rating Scale part III (MDS UPDRS Part III), and the benefit lasted through a 12-week washout, which suggested possible disease modification
The clinical trial programme for semaglutide 2.4 mg (STEP trials), which included over 4,500 participants followed for up to 68 weeks as documented in the European Public Assessment Report (EPAR), did not identify diverticulitis as a treatment-emergent adverse event occurring at rates higher than placebo
Compare your closing metrics to your baseline, read your subjective trend lines, and note the confounders you documented along the way
Traxxas even has one that is over 12000mAh
The EVOKE result is consistent with this logic: semaglutide is a large, acylated molecule with poor brain penetrance, and it did not show benefit in Alzheimers disease